Head-To-Head Comparison of Subcutaneous Abatacept Versus Adalimumab on Background Methotrexate in RA: Blinded Two-Year Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Study
Author(s):
Weinblatt, M.; Schiff, M.; Valente, R.; Heijde, D. van der; Citera, G.; Elegbe, A.; Maldonado, M.; Fleischmann, R.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-07-31
Language
English
Is part of
Journal of Rheumatology (2014), Vol. 41, no. 7, p. 1476-1476
